Is CTT Pharmaceutical Holdings, Inc. (CTTH) a Buy, Sell, or Hold?
OTC : CTTH
CTT Pharmaceutical Holdings, Inc.
$0.066 USD
$0.0 (1.54%)
- Volume
- 43.85K
- Average Volume
- 20.61K
- Market Capitalization
- $3.94M
- P/E Ratio
- -26.40
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.10
- Year Low
- $0.04
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.20
Company Overview
OTC
Ryan Khouri
Medical - Pharmaceuticals
Healthcare
CTTH
1
US
USD
Liquidity Metrics
0.46
0.20
0.20
0.20
0.00
Sales & Valuation
-$
0.00
94.41
-62.42
0.00
Profitability
-$0.0027
-$155.91K
0.00%
0.00%
-242.12%
-206.81%
P/E Metrics
-26.40
0.46
0.46
Analyst Price Target & Rating
1/5
0 Analysts
%
Financial Health Scores
-78.02
1/9
-$27829.0
$76195.0
$34918.0
-$115.68K
Key Metrics (TTM)
$3.95M
0.00
-36.22
0.20
-242.12%
-192.52%
-4.04%
-1.60%
0 days
Company Executives
| Name | Title |
|---|---|
| Pankaj Modi | Founder & Consultant |
| Ryan Khouri | Chief Executive Officer |
| Marc Lakmaaker | Special Advisor & Senior Vice President of Commercial Development |
Poll Results
No votes yet today — be the first to share your view!
About CTT Pharmaceutical Holdings, Inc. (OTC:CTTH) Stock
CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The company’s technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion. Its principal asset is a patented orally administered dissolvable strip. The company is based in Tampa, Florida. ...
CTT Pharma Receives U.S. Patent Approval for Nicotine, Vitamins, and Caffeine Delivery Technology
2026-08-10 06:00:00
August 10, 2026 – TheNewswire - CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) is pleased to announce the company has been formally approved by the U.S. Patent Office for a continuation-in-part(CIP). A continuation-in-part (CIP) patent is a new application that repeats a substantial portion of an earlier “parent” application while adding brand new subject matter or improvements. The U.S. Patent Office has issued a patent number and will issue the patent on August 11, 2026. The CIP patent adds additional protection for nicotine, vitamins, and caffeine utilizing our micelle delivery technology. This new patent allows CTT Pharma the ability to use our technology to make dissolvable strips, gum, pouches, lozenges, and dissolving tablets. CTT will continue to spend time strengthening our patent portfolio as the company believes patents are an important aspect of the business. About CTT Pharmaceutical Holdings, Inc.
CTT Pharma Receives SEC Approval
2026-08-05 06:00:00
August 5, 2026 – TheNewswire - CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) is pleased to announce the company has been formally approved by the SEC for our S-1 and will now be a SEC reporting company. This is an important milestone as CTT Pharma is now an audited, SEC reporting company on the OTCQB and will start filing an SEC form 8-K when material events occur. CTT will update shareholders as more news becomes available. About CTT Pharmaceutical Holdings, Inc.
CTT Pharma Signs LOI with European Company
2026-05-14 06:00:00
May 14, 2026 – TheNewswire - CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) has signed an LOI with a company in Europe for a potential strategic partnership. A partnership with this group would allow CTT additional opportunities to monetize the company's patented technology in Europe and the United States. CTT Pharma will notify shareholders as more information becomes available. About CTT Pharmaceutical Holdings, Inc.
Frequently Asked Questions
-
What is the current CTT Pharmaceutical Holdings, Inc. (CTTH) stock price?
-
CTT Pharmaceutical Holdings, Inc.(OTC:CTTH) stock price is $0.066 in the last trading session. During the trading session, CTTH stock reached the peak price of $0.1 while $0.035 was the lowest point it dropped to. The percentage change in CTTH stock occurred in the recent session was 1.54% while the dollar amount for the price change in CTTH stock was $0.0.
-
CTTH's industry and sector of operation?
-
The OTC listed CTTH is part of Medical - Pharmaceuticals industry that operates in the broader Healthcare sector.
-
Who are the executives of CTTH?
-
Pankaj Modi | Founder & Consultant
Ryan Khouri | Chief Executive Officer
Marc Lakmaaker | Special Advisor & Senior Vice President of Commercial Development
|
| -
How many employees does CTTH have?
-
Number of CTTH employees currently stands at 1. CTTH operates from 3853 Northdale Blvd, Tampa, FL 33624, US.
-
Link for CTTH official website?
-
Official Website of CTTH is: https://www.cttpharmaceuticals.com
-
How do I contact CTTH?
-
CTTH could be contacted at phone #613-241-9959 and can also be accessed through its website. CTTH operates from 3853 Northdale Blvd, Tampa, FL 33624, US.
-
How many shares of CTTH are traded daily?
-
The average number of CTTH shares traded daily for last 3 months was 20.61K.
-
What is the market cap of CTTH currently?
-
The market value of CTTH currently stands at $3.94M with its latest stock price at $0.066